Medicine and Dentistry
Therapeutic Procedure
78%
Patient
55%
Psychosis
53%
Depression
50%
Early Intervention
50%
Clozapine
33%
Cohort Analysis
33%
Fluorine-18
31%
DOPA
31%
Bipolar Disorder
28%
Effect Size
28%
Dopamine Agonist
28%
Disease
28%
Hospital
26%
Serotonin
25%
Anterior Cingulate
25%
Proton Nuclear Magnetic Resonance
25%
Cingulate Cortex
25%
Clinical Significance
25%
Human
25%
Dopamine
25%
Glutamic Acid
25%
Cost-Effectiveness Analysis
25%
Apomorphine
25%
Genetic Variability
25%
Regulatory Mechanism
25%
Drug Therapy
23%
Inpatient
22%
Placebo
21%
Analysis
19%
Hamilton Rating Scale for Depression
17%
Electronic Health Record
16%
Clinical Research
16%
Male
16%
Person
16%
Antidepressant
14%
Volunteer
13%
Pathophysiology
12%
Molecular Imaging
12%
Age
11%
Follow up
11%
Typical Antipsychotic
10%
Symptom
10%
Health
9%
Dopamine Metabolism
9%
Chemotherapeutic Agent
8%
Drug
8%
Mental Health Service
8%
Incidence
8%
Emergency Department
8%
Neuroscience
Psychosis
100%
Positron Emission Tomography
75%
Dopamine
55%
Antipsychotic
38%
DOPA
34%
Dementia Praecox
33%
Dopaminergic
33%
Magnetic Resonance Imaging
26%
Anterior Cingulate Cortex
25%
Depression
25%
Nuclear Magnetic Resonance Spectroscopy
25%
Apomorphine
25%
Lithium
25%
Glutamic Acid
25%
Positron Emission Tomography
25%
Antidepressant
14%
Striatum
11%
Placebo
10%
Bipolar Disorder
8%
Negative Syndrome
8%
Major Depressive Disorder
7%
Molecular Imaging
6%
Functional Connectivity
5%
Positive Syndrome
5%
Support Vector Machine
5%
Frontal Lobe
5%
Clozapine
5%
Nursing and Health Professions
Cohort Analysis
33%
Clozapine
33%
DOPA
25%
Fluorine 18
25%
Psychosis
25%
Dopamine Receptor Stimulating Agent
25%
Apomorphine
25%
Polyethylene Terephthalate
25%
Patient
25%
Early Intervention
25%
Cost Effectiveness Analysis
25%
Clinical Effectiveness
25%
Young People
25%
Analysis
19%
Hospital
16%
Electronic Health Record
16%
Follow up
11%
Placebo
10%
Mental Hospital
9%
Incidence
8%
Emergency Ward
8%
Typical Antipsychotic
8%
Publication
8%
Mental Health Service
8%
Error
7%
Discharge
6%
